emergent biosolutions inc (EBS:New York)
Transactions by EMERGENT BIOSOLUTIONS INC (EBS) in the last 6 months
Emergent BioSolutions, Inc. (NYSE:EBS) agreed to acquire Cangene Corp. (TSX:CNJ) for approximately $220 million in cash on December 11, 2013. Emergent will acquire all of the outstanding common shares of Cangene in an all-cash transaction valued at $3.24 per share on a fully diluted basis. In connection with the transaction, Emergent has secured committed debt financing from Bank of America Merrill Lynch along with PNC Bank and J.P. Morgan Chase Bank, N.A., totaling ...
Heartland Advisors, Inc.
Resolute Funds Ltd.
Sherman Foundation, Endowment Arm
Miller Thomson LLP
|Bavarian Nordic A/S||kr82.00 DKK||-3.00|
|Chimerix Inc||$14.14 USD||+0.42|
|ImmunoGen Inc||$14.13 USD||0.00|
|Spectrum Pharmaceuticals Inc||$9.18 USD||-0.11|
|Valneva SE||€4.11 EUR||-0.23|
|View Industry Companies|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26